Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
about
The effect of antihypertensive drugs on endothelial function as assessed by flow-mediated vasodilation in hypertensive patients.The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]iThe assessment of endothelial function: from research into clinical practice.Fast and sensitive analysis of beta blockers by ultra-high-performance liquid chromatography coupled with ultra-high-resolution TOF mass spectrometry.Nebivolol and quinapril reduce p-wave duration and dispersion in hypertensive patients.Nebivolol (bystolic), a novel Beta blocker for hypertensionLipid simulations: a perspective on lipids in action.The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.Pharmacokinetics of selective β1-adrenergic blocking agents: prescribing implications.Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model.Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity.Controlled heterocyclization/cross-coupling domino reaction of β,γ-allendiols and α-allenic esters: method and mechanistic insight for the preparation of functionalized buta-1,3-dienyl dihydropyrans.Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats.
P2860
Q35830347-B359A7B3-09C4-428F-B32B-CA79BC2A3B0CQ36157478-E9FB0151-4F31-40BB-A4F3-2347105D7D63Q36190146-ADEAD1EB-5FAC-44BC-9858-B6B91B0D7B71Q36214769-61D1241F-84DF-4B96-A170-39BF456FCC92Q37195973-B7F9264F-86DE-4B46-BAA7-A419BDAD66D2Q37229207-116C66A4-2B88-444D-A443-C5853D4A91BFQ37858333-9C6F9C1D-97E3-4B92-B669-27C0CEB18632Q38012491-D15E984B-4BFD-4520-A13B-6AE9EABE3772Q38226352-67EA75F1-4459-4202-82EB-FCD70455C7B9Q41203153-E18DA17B-704A-4EAA-A623-B25D5DB2574EQ43857564-EFA3B7CA-5302-4DF6-98B9-D59AE5089C6FQ45711234-9695E6CB-5532-4F0D-9733-DEF97677AE49Q46313772-455558E8-F127-496A-9988-9E28A0854BC7
P2860
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
@en
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
@nl
type
label
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
@en
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
@nl
prefLabel
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
@en
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
@nl
P2860
P356
P1476
Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
@en
P2093
L Michael Prisant
P2860
P304
P356
10.1177/0091270007310378
P577
2007-12-14T00:00:00Z